Prognostic value of alpha-fetoprotein and des-gamma-carboxyprothrombin in hepatocellular carcinoma treated with transarterial chemoembolization
The combination of AFP and DCP provides a valuable serum biomarker for assessing the efficacy of TACE in patients with HCC. The goal for TACE treatment in dual-positive patients is to achieve a dual response for AFP and DCP.
Authors
- Yapan Guo
- M. Li
- P. Jeremy Wang (ORCID: https://orcid.org/0000-0003-2311-4089)
- Shitao Lu
- Tongqing Xue
- Zhi Li
- Zhao Liu
Institutions
- Xuzhou Medical College (CN)
- Soochow University (CN)
- Suzhou Municipal Hospital (CN)
- Second People’s Hospital of Huai’an (CN)
- First Affiliated Hospital of Soochow University (CN)
- The Fifth People’s Hospital of Suzhou (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2025-12-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_614_25
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00